BusinessSeeThruEquity Initiates Coverage on AXIM® Biotechnologies (OTC: AXIM) With a Target Price of $17.0By Nasdaq OMXMay 16, 2017, 2:00 PM UTC
BusinessSeeThruEquity Initiates Coverage on AXIM® Biotechnologies (OTC: AXIM) With a Target Price of $17.0By Nasdaq OMXMay 16, 2017, 2:00 PM UTC